AI Science Tracker
EN

Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears.

Affiliation not stated in the reviewed material · 29 Oct 2026 · medicine

Discovery

Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears.

Source check: Source checked. Not independent scientific confirmation.

Finding: Attention-based multiple-instance learning predicts IDH1 mutation from bone-marrow smears in 436 AML patients across four centers with pooled ROC-AUC 0.81 and a clinically specific retrospective evaluation. Published in npj Precision Oncology.

Technology: Attention-based multiple-instance learning predicts IDH1 mutation status from bone-marrow smear images.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Attention-based multiple-instance learning predicts IDH1 mutation status from bone-marrow smear images.
Test and result
Full text states the cohort/data, comparison and evaluation for this bounded claim.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41698-026-01762-x

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.